Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
Novo Nordisk and Viatris have agreed to resolve a patent dispute over Novo's blockbuster weight-loss drugs Ozempic and Wegovy ...
Novo Nordisk (NVO) and Viatris (VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo ...
Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer ...
The US Supreme Court declined to take up a company’s challenge to US Patent & Trademark Office decisions canceling four ...
Route 92 Medical announced today that it filed a lawsuit against Q'Apel Medical alleging the infringement of five catheter ...
Despite years of rumors and an extensive body of patents regarding a smart Apple Ring, a new report claims the company has no ...
Data-driven O&M supercharging solar asset performance. Solar wafer prices steady amid improving supply-demand balance. And ...
AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications ...
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...
Novo Nordisk ($NVO) and Viatris ($VTRS) have agreed to settle a dispute over patents for Novo’s weight-loss drugs, Ozempic ...
17h
U.S. Supreme Court denied United Therapeutics’ petition to appeal rulings that found all claims of U.S. Patent No. 10,716,793 (‘793 Patent) were ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback